You are here: Industry Insights > pricing

News List

Winning Trump’s praise was easy for Pfizer. Wall Street and the Hill? Not so much fiercepharma
July 18, 2018
When President Donald Trump praised Pfizer on Twitter for delaying price hikes on 40 of its drugs last week
Women's hormone drug prices have climbed for years, but controversy hasn't ensued. Why? fiercepharma
June 05, 2018
Another case hasn't garnered the same attention—and maybe that's because people just don't like to talk about vaginas.
CCI to study pricing issue in pharma, healthcare sector expressbpd
September 15, 2017
The proposal, mooted by the regulator, comes amid concerns over anti-competitive practices in the pharmaceutical and healthcare sectors
NPPA issues notice to pharmaceutical firms for non-compliance of pricing provisions pharmaceutical-technology
May 27, 2017
Indian drug price regulator the National Pharmaceutical Pricing Authority (NPPA) has issued notices to several pharmaceutical companies that have marketed combination drugs without complying Drug Price Control Order (DPCO) 2013.
European Commission launches probe into Aspen's pricing practices for five cancer drugs firstwordpharma
May 16, 2017
The European Commission announced Monday a formal investigation into Aspen Pharmacare over suggestions that the company engaged in "excessive pricing" for five cancer medicines.
QuintilesIMS Announces Pricing of Senior Notes IMS Health
February 24, 2017
Quintiles IMS Holdings, Inc. announced the pricing of the offering of €1.425 billion in gross proceeds of senior notes to be issued by its wholly owned subsidiary, Quintiles IMS Incorporated (the “Issuer”).
Ocular Therapeutix Announces Pricing of Public Offering of Common Stock firstwordpharma
January 25, 2017
Ocular Therapeutix, Inc. announced today the pricing of a registered underwritten public offering of 3,571,429 shares of its common stock at a public offering price of $7.00 per share...
Kaléo Announces U.S. Availability and Pricing of AUVI-Q® (Epinephrine Injection, USP) Auto-Injector americanpharmaceuticalreview
January 22, 2017
Kaléo has announced the AUVI-Q® (epinephrine injection, USP) Auto-injector will be available by prescription starting February 14th, and announced AUVI-Q AffordAbility, a first-of-its-kind access program for AUVI-Q.

Previous page 1 2 Next page